The Nuclear Medicine department has been functioning on an academical level since 2004 and on a clinical level since 2007. The department participates in the educational courses of the Faculty of Medicine in the University of Thessaly, as well as in the clinical and research activities of the University Hospital of Larissa, conducting all the in-vitro and scintigraphic (SPECT) examinations of Nuclear Medicine.
Clinical evaluation of the neurotransmitter/hormone levels as indices of the psychokinetic status of post-traumatic patients.
Measurement of ghrelin and adiponectin levels in patients with bronchial asthma.
Measurement of ghrelin and adiponectin levels in patients with heart failure.
Measurement of S-100A levels in patients with idiopathic infectious bowel diseases.
Measurement of S-100A levels in patients with automatic subarachnoid hemorrhage.
Brain Perfusion SPECT studies with mapping of Broadmann areas in patients with Alzheimer’s Disease and Frontotemporal Dementia”.
Correlation of prognostic parameters after heart exercise testing with myocardial perfusion SPECT findings in diabetic patients.
Application of brain SPECT using new radiopharmaceuticals for the diagnosis, monitoring and assessment of treatment response in patients with Parkinson’s Disease.
Investigation of the incremental diagnostic and prognostic parameters that myocardial perfusion (SPECT) imaging provides, using new 99m-Tc radiolabelled pharmaceuticals in specific patient groups (e.g. patients after coronary revascularization, diabetic patients).
Correlation of gene expression in patients with coronary disease with myocardial perfusion (SPECT) findings.
Development and clinical application of a 3D dose calculation and internal dosimetry software for nuclear medicine patients.
Investigation of gene expression in patients with myocardial ischemia (2005 – up to date).
Application of brain perfusion SPECT in patients with Frontotemporal Dementia and Alzheimer’s Disease (2005 – up to date).
Development of dedicated γ-camera systems for experimental subjects and small organs (2010 – up to date).
Development and evaluation of an open-source software for the iterative reconstruction and attenuation-scatter correction of SPECT images (2009- up to date).
Investigation of Central Nervous System tumors with Positron Emission Tomography (PET) – Application of new PET radiopharmaceuticals (2011 – up to date).
Functional optimization of Positron Emission Tomography systems (PET) (2011 – today).
Evaluation of new diagnostic and prognostic parameters using myocardial perfusion SPECT. Application of new techniques (2011 – up to date). Project budget: 40,000 euros (Project code: 4153).
Optimization of Clinical Protocols for Personalized Cancer Diagnosis and Treatment Using Advanced Anthropomorphic Phantoms, Program "Archimedes". Project budget: 81,000 euros.
Exercise, smoking and alcohol: Investigation of mechanisms and interventions for prevention, cessation & awareness – escape Project budget: 525,000 euros (Funded by "Thalis" Program, 2011)
2 (two) Dual-Head Tomographic-γ-cameras.
2 (two) γ-counters.
Software development for 3D dose calculation and internal dosimetry in nuclear medicine patients.
Identification of polymorphisms correlated to defective myocardial perfusion.
| Surname | Name | Profession-Position | Phone Number | |
|---|---|---|---|---|
|
Παναγιώτης
|
Γεωργούλιας
|
Διευθυντής
|
pgeorgoul@med.uth.gr
|
+30 2413 502918
|
|
Βαλοτάσιου
|
Βαρβάρα
|
Επίκουρος Καθηγητής
|
valotasiou@med.uth.gr
|
+30 2413 502916
|
|
Ψημάδας
|
Δημήτριος
|
Ανώτερος Ερευνητής
|
dpsimad@gmail.com
|
+30 2413 502916
|
|
Ζιάκα
|
Αναστασία
|
Τεχνικός
|
+30 2413 502916
|
|
|
Μπανιώρα
|
Ελένη
|
Τεχνικός
|
+30 2413 502916
|